HIGHLIGHTS
- who: Ntlotlang Mokgautsi and colleagues from the Taipei Medical University and Academia Sinica, Taipei, Taiwan have published the Article: Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer, in the Journal: Cells 2023, 340 of 21/06/2022
- what: The authors explored computational simulations through bioinformatics analysis and identified the overexpression of c-Met/GSK3u03b2/MYC/CCND1 oncogenic signatures that were associated with cancer progression drug resistance metastasis and poor clinical outcomes in CRC. The authors evaluated the anticancer effects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.